![Jane Wasman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jane Wasman
Direktor/Vorstandsmitglied bei
SELLAS LIFE SCIENCES GROUP, INC.
Vermögen: 1 Mio $ am 31.07.2026
Profil
Jane Wasman is Chairman at Sellas Life Sciences Group Ltd. since 2017.
Ms. Wasman serves as Independent Director at Rigel Pharmaceuticals, Inc. since 2019.
Ms. Wasman is also Independent Director at SELLAS Life Sciences Group, Inc. since 2017.
Former roles include Chairman at Athersys, Inc. from 2023 to 2024, Chairman at SELLAS Life Sciences Group, Inc. from 2017 to 2024, Director at Biotie Therapies Oy, Director at Cytovia Therapeutics, Inc., Director at New York Biotechnology Association, Inc., Staff Vice President & Associate General Counsel at Schering-Plough Corp.
from 1995 to 2004, Secretary & President-International at Acorda Therapeutics, Inc. from 2012 to 2019, Associate General Counsel-Veteran Affairs at the United States Senate, and President, Secretary & General Counsel at Acorda Therapeutics Ltd. from 2012 to 2019.
Education includes undergraduate studies at Princeton University and graduate studies at Harvard Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.05.2026 | 18 250 ( 0,1 % ) | 671 783 $ | 31.07.2026 | |
| 15.04.2026 | 42 900 ( 0,02 % ) | 429 429 $ | 31.07.2026 |
Aktive Positionen von Jane Wasman
| Unternehmen | Position | Beginn |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Direktor/Vorstandsmitglied | 01.06.2024 |
| RIGEL PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 26.03.2019 |
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorsitzender | 29.12.2017 |
Ehemalige bekannte Positionen von Jane Wasman
| Unternehmen | Position | Ende |
|---|---|---|
| ATHERSYS, INC. | Vorsitzender | 01.04.2024 |
SELLAS Life Sciences Group, Inc. /Old/
 SELLAS Life Sciences Group, Inc. /Old/ BiotechnologyHealth Technology Operates clinical-stage biopharmaceutical company | Vorsitzender | 01.01.2024 |
| ACORDA THERAPEUTICS, INC. | General Counsel | 31.12.2019 |
Acorda Therapeutics Ltd.
 Acorda Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for nervous system disorders | Präsident | 01.12.2019 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von Jane Wasman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
United States Senate
 United States Senate General GovernmentGovernment Engages in the operations of the senate | Government |
Harvard Law School
 Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SELLAS Life Sciences Group, Inc. /Old/
SELLAS Life Sciences Group, Inc. /Old/ BiotechnologyHealth Technology Operates clinical-stage biopharmaceutical company | Health Technology |
Acorda Therapeutics Ltd.
Acorda Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for nervous system disorders | Health Technology |
SELLAS Life Sciences Group, Inc.
 SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
